ID: MRFR/HC/10167-HCR | 128 Pages | Author: Kinjoll Dey | March 2024
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL RAPID DIAGNOSTICS MARKET, BY PRODUCT
6.1. Overview
6.2. Over the Counter (OTC) Kits
6.3. Professional Kits
7. GLOBAL RAPID DIAGNOSTICS MARKET, BY APPLICATION
7.1. Overview
7.2. Blood Glucose Testing
7.3. Infectious Disease Testing
7.4. Cardiometabolic Testing
7.5. Pregnancy & Fertility Testing
7.6. Fecal Occult Blood Testing
7.7. Coagulation Testing
7.8. Toxicology Testing
8. GLOBAL RAPID DIAGNOSTICS MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Rapid Diagnostics Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Rapid Diagnostics Market,
9.7. Key Developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2022
9.8.2. Major Players R&D Expenditure. 2022
10. COMPANY PROFILES
10.1. Abaxis
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Becton
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Dickinson & Company
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Bio-Rad Laboratories
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Accriva Diagnostics
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. ACON Laboratories Inc
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Hologic Inc
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Abbott Laboratories
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Roche Diagnostics
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Bayer HealthCare Pharmaceuticals LLC
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Cepheid Inc
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Products Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL RAPID DIAGNOSTICS MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL RAPID DIAGNOSTICS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 US: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 8 US: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 CANADA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 10 CANADA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 3 GERMANY: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 FRANCE: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 6 FRANCE: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 ITALY: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 8 ITALY: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 SPAIN: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 10 SPAIN: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 UK: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 12 UK: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 17 JAPAN: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 18 JAPAN: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 CHINA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 20 CHINA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 21 INDIA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 22 INDIA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 AUSTRALIA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 24 AUSTRALIA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 33 AFRICA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 34 AFRICA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: RAPID DIAGNOSTICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: RAPID DIAGNOSTICS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RAPID DIAGNOSTICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RAPID DIAGNOSTICS MARKET
FIGURE 4 GLOBAL RAPID DIAGNOSTICS MARKET, SHARE (%), BY PRODUCT, 2022
FIGURE 5 GLOBAL RAPID DIAGNOSTICS MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 NORTH AMERICA: RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 EUROPE: RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 ASIA-PACIFIC: RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 REST OF THE WORLD: RAPID DIAGNOSTICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 GLOBAL RAPID DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 12 ABAXIS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 ABAXIS: SWOT ANALYSIS
FIGURE 14 BECTON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 BECTON: SWOT ANALYSIS
FIGURE 16 DICKINSON & COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 DICKINSON & COMPANY: SWOT ANALYSIS
FIGURE 18 BIO-RAD LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 BIO-RAD LABORATORIES: SWOT ANALYSIS
FIGURE 20 ACCRIVA DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 ACCRIVA DIAGNOSTICS: SWOT ANALYSIS
FIGURE 22 ACON LABORATORIES INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 ACON LABORATORIES INC: SWOT ANALYSIS
FIGURE 24 HOLOGIC INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 HOLOGIC INC: SWOT ANALYSIS
FIGURE 26 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ABBOTT LABORATORIES: SWOT ANALYSIS
FIGURE 28 ROCHE DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 ROCHE DIAGNOSTICS: SWOT ANALYSIS
FIGURE 30 BAYER HEALTHCARE PHARMACEUTICALS LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 BAYER HEALTHCARE PHARMACEUTICALS LLC: SWOT ANALYSIS
FIGURE 32 CEPHEID INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 CEPHEID INC: SWOT ANALYSIS
Rapid Diagnostics Market Segmentation
Rapid Diagnostics Application Outlook (USD Billion, 2018-2032)
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Rapid Diagnostics Product Outlook (USD Billion, 2018-2032)
Over the Counter (OTC) Kits
Professional Kits
Rapid Diagnostics Regional Outlook (USD Billion, 2018-2032)
North America Outlook (USD Billion, 2018-2032)
North America Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
North America Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
US Outlook (USD Billion, 2018-2032)
US Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
US Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
CANADA Outlook (USD Billion, 2018-2032)
CANADA Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
CANADA Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Europe Outlook (USD Billion, 2018-2032)
Europe Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Europe Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Germany Outlook (USD Billion, 2018-2032)
Germany Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Germany Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
France Outlook (USD Billion, 2018-2032)
France Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
France Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
UK Outlook (USD Billion, 2018-2032)
UK Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
UK Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
ITALY Outlook (USD Billion, 2018-2032)
ITALY Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
ITALY Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
SPAIN Outlook (USD Billion, 2018-2032)
Spain Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Spain Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Rest Of Europe Outlook (USD Billion, 2018-2032)
Rest Of Europe Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
REST OF EUROPE Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Asia-Pacific Outlook (USD Billion, 2018-2032)
Asia-Pacific Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Asia-Pacific Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
China Outlook (USD Billion, 2018-2032)
China Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
China Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Japan Outlook (USD Billion, 2018-2032)
Japan Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Japan Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
India Outlook (USD Billion, 2018-2032)
India Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
India Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Australia Outlook (USD Billion, 2018-2032)
Australia Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Australia Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
Rest of Asia-Pacific Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Rest of Asia-Pacific Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Rest of the World Outlook (USD Billion, 2018-2032)
Rest of the World Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Rest of the World Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Middle East Outlook (USD Billion, 2018-2032)
Middle East Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Middle East Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Africa Outlook (USD Billion, 2018-2032)
Africa Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Africa Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits
Latin America Outlook (USD Billion, 2018-2032)
Latin America Rapid Diagnostics by Application
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Latin America Rapid Diagnostics by Product
Over the Counter (OTC) Kits
Professional Kits